Research Article
BibTex RIS Cite

Birth Control Methods Used by Men and Their Attitudes towards the Male Birth Control Pill

Year 2020, Volume: 14 Issue: 4, 613 - 620, 20.12.2020
https://doi.org/10.21763/tjfmpc.762554

Abstract

The present study aims to determine the Turkish men’s knowledge level on family planning and contraceptive methods, contraception preferences, and their attitudes towards male contraceptive pills, which is not one of the contraceptive methods used in our country, among 18+-year-old men, who applied to family health center polyclinic. In this prospective study, a questionnaire consisting of 19 questions was conducted to 527 men over the age of 18. It was observed that 86.3% of the participants (53.8% of men, 32.8% of women and 13.4% of both genders) used contraceptive methods. The most commonly used contraceptive methods among men are as follows; condoms (57.8%), coitus interruptus (40.4%) and other methods (1.8%). Among the reasons for not wanting to use; the rate of side effects was 53.7%, the ease and success rate of other methods was 16.2%, the difficulty of use was 13.6%, and the rate of other reasons was 16.5%. There was a statistically significant relationship between educational status, use of the contraceptive method, and status of knowing that there is a male contraceptive pill (p=0.0001, p=0.0001). Male contraceptive pills can be an important option in family planning if Turkish men, who are concerned about the side effects of the contraceptive pill, are provided with the necessary information, and also have easy access to male contraceptive pills.

Supporting Institution

Yok

Thanks

We’d like to thank Dr.Şirin Küçük, and Halime Kılıç for their contributions to the present study

References

  • 1. World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2018 update). Baltimore and Geneva: CCP and WHO, 2018.
  • 2. Amory JK. Male contraception. Fertil Steril. 2016 Nov;106(6):1303-1309. doi: 10.1016/j.fertnstert. 2016.08. 036. Epub 2016 Sep 24.
  • 3. Ateşer GB, Güzel E, Kaya S, Sivri Aydın D, Nazife Şahbaz, Kurt Durmuş M. Türk Kadınlarının Gebelikten Korunma Yöntem Tercihleri. Okmeydanı Tıp Dergisi 33(4):241-246, 2017 doi:10.5222/otd.2017.1094
  • 4. Stover J, Rosen JE, Carvalho MN, Korenromp EL, Friedman HS, Cogan M, et al. The case for investing in the male condom. PLoS One. 2017 May 16;12(5):e0177108. doi: 10.1371/journal.pone.0177108. eCollection 2017
  • 5. Trussell J. Contraceptive failure in the United States. Contraception 2011; 83: 397–404.
  • 6. United Nations, Department of Economic and Social Affairs, Population Division. Trends in Contraceptive Use Worldwide 2015 (ST/ESA/SER.A/349) 2015; 23-26.
  • 7. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü. 2018 Türkiye Nüfus ve Sağlık Araştırması. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü, T.C. Kalkınma Bakanlığı ve TÜBİTAK. Aile planlanması. Türkiye; Ankara 2018; 83-105.
  • 8. Güngör S, Başer İ, Göktolga Ü, Özkömür E, Keskin U. Koitus interruptus (geri çekme) yönteminin etkinliği ve eğitim seviyesinin önemi. Gülhane Tıp Dergisi 2006; 48: 8-10.
  • 9. Fu TC, Hensel DJ, Beckmeyer JJ, Dodge B, Herbenick D. Considerations in the Measurement and Reporting of Withdrawal: Findings from the 2018 National Survey of Sexual Health and Behavior. J Sex Med. 2019 Aug;16(8):1170-1177. doi: 10.1016/j.jsxm.2019.05.022. Epub 2019 Jul 11.
  • 10. Jing HC, Stephanie T. Page. The current state of male hormonal contraception. Pharmacology & Therapeutics 2016; 163: 109–117.
  • 11. Vanya M, Devosa I, Barabás K, Bártfai G, Kozinszky Z. Choice of contraception at 6-8 weeks postpartum in south-eastern Hungary. Eur J Contracept Reprod Health Care. 2018 Feb;23(1):52-57. doi: 10.1080/13625187.2017.1422238. Epub 2018 Feb 2.
  • 12. Orji EO, Onwudiegwu U. Contraceptive practice among married market men in Nigeria. East Afr Med J. 2003 Jul;80(7):357-60.
  • 13. Kovavisarach E, Saringcarnan P. Coitus interruptus in female patients seeking services at Obstetrics and Gynecology Department in Rajavithi Hospital. J Med Assoc Thai. 2010 Dec;93(12):1356-9.
  • 14. Agyei WK, Migadde M. Demographic and sociocultural factors influencing contraceptive use in Uganda. J Biosoc Sci. 1995 Jan;27(1):47-60.
  • 15. Fagbamigbe AF, Adebowale AS, Morhason-Bello I. Survival analysis of time to uptake of modern contraceptives among sexually active women of reproductive age in Nigeria. BMJ Open. 2015 Dec 15;5(12):e008371. doi: 10.1136/bmjopen-2015-008371.
  • 16. Abiodun OM, Balogun OR. Sexual activity and contraceptive use among young female students of tertiary educational institutions in Ilorin, Nigeria. Contraception. 2009 Feb;79(2):146-9. doi: 10.1016/j.contraception.2008.08.002. Epub 2008 Nov 17.
  • 17. Paudel YR, Acharya K. Fertility Limiting Intention and Contraceptive Use among Currently Married Men in Nepal: Evidence from Nepal Demographic and Health Survey 2016. Biomed Res Int. 2018 Dec 23;2018:5970705. doi: 10.1155/2018/5970705. eCollection 2018.
  • 18. Heinemann K, Saad F, Wiesemes M, White S, Heinemann L. Attitudes toward male fertility control: results of a multinational survey on four continents. Human Reproduction Vol.20, No.2 pp. 2005; 549–556.
  • 19. Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Hormonal Male Contraception Summit GroupRate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006 Apr 29;367(9520):1412-20.
  • 20. Piotrowska K, Wang C, Swerdloff RS, Liu PY. Male hormonal contraception: hope and promise. Lancet Diabetes Endocrinol 2017;5: 214–23.
  • 21. Wang C, Festin MPR, Swerdloff RS. Male Hormonal Contraception: Where Are We Now? Curr Obstet Gynecol Rep (2016) 5:38–47 DOI 10.1007/s13669-016-0140-8
  • 22. Fernández-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010 Jun;95(6):2560-75. doi: 10.1210/jc.2009-2575.
  • 23. Martin CW, Anderson RA, Cheng L, Ho PC, van der Spuy Z, Smith KB, et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod. 2000 Mar;15(3):637-45.
  • 24. Glasier A. Acceptability of contraception for men: a review. Contraception 82 (2010) 453–456.
  • 25. Weston GC, Schlipalius ML, Bhuinneain MN, Vollenhoven BJ. Will Australian men use male hormonal contraception? A survey of a postpartum population. Med J Aust. 2002 Mar 4;176(5):208-10.
  • 26. Meriggiola MC, Cerpolini S, Bremner WJ, Mbizvo MT, Vogelsong KM, Martorana G, et al. Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. Hum Reprod. 2006 Aug;21(8):2033-40. Epub 2006 May 26.
  • 27. Eberhardt J, van Wersch A, Meikle N. Attitudes towards the male contraceptive pill in men and women in casual and stable sexual relationships. J Fam Plann Reprod Health Care. 2009 Jul;35(3):161-5. doi: 10.1783/147118909788707986.
  • 28. Dorman E, Bishai D. Demand for male contraception. Expert Rev Pharmacoecon Outcomes Res. 2012 Oct;12(5):605-13. doi: 10.1586/erp.12.52.

Erkeklerin Kullandığı Doğum Kontrol Yöntemleri ve Erkek Doğum Kontrol Hapına Karşı Tutumları

Year 2020, Volume: 14 Issue: 4, 613 - 620, 20.12.2020
https://doi.org/10.21763/tjfmpc.762554

Abstract

Çalışmanın amacı aile hekimliği polikliniğine başvuran 18 yaş üstü erkeklerin aile planlaması ve doğum kontrol yöntemleri hakkındaki bilgi düzeyleri, doğum kontrol yöntemi tercihleri ve ülkemizde kullanılan doğum kontrol yöntemleri arasında yer almayan erkek doğum kontrol hapına Türk erkeklerin bakış açılarını belirlemeye çalışmaktır. Prospektif tipte planlanan çalışmada 18 yaş üstü 527 erkeğe toplam 19 sorudan oluşan anket yapıldı. Katılımcıların% 86.3'ü (Erkeklerin % 53,8’i, kadınların % 32,8’i ve her iki cinsiyetin % 13,4’ü) kontraseptif yöntem kullandığı belirlenmiştir. Erkekler arasında en sık kullanılan kontraseptif yöntemler prezervatif (% 57,8), coitus interruptus (% 40,4) ve diğer yöntemlerdir (% 1,8). Erkek doğum kontrol hapı kullanabileceğini belirten erkeklerin oranı % 21,8 iken kararsız erkeklerin oranı % 17,1'di. Kullanmak istememe nedenlerinin oranları arasında; yan etki oranı % 53,7, diğer yöntemlerin kolaylık ve başarı oranı % 16,2, kullanım güçlüğü % 13,6 ve diğer nedenlerin oranı % 16,5 idi. Eğitim durumu ile doğum kontrol yöntemi kullanma ve erkek doğum kontrol hapı olduğunu bilme durumu arasında istatistiksel olarak anlamlı bir ilişki vardı (sırasıyla p = 0,0001, p = 0,0001). Türk erkeklerinin doğum kontrol hapının yan etkileri konusunda ki endişelerinin giderilmesi, gerekli bilgilendirmelerin yapılması ve erkek doğum kontrol hapına ulaşımının kolay olması durumunda erkek doğum kontrol hapları aile planlamasında önemli bir seçenek olabilir.                                                                                                                  

References

  • 1. World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2018 update). Baltimore and Geneva: CCP and WHO, 2018.
  • 2. Amory JK. Male contraception. Fertil Steril. 2016 Nov;106(6):1303-1309. doi: 10.1016/j.fertnstert. 2016.08. 036. Epub 2016 Sep 24.
  • 3. Ateşer GB, Güzel E, Kaya S, Sivri Aydın D, Nazife Şahbaz, Kurt Durmuş M. Türk Kadınlarının Gebelikten Korunma Yöntem Tercihleri. Okmeydanı Tıp Dergisi 33(4):241-246, 2017 doi:10.5222/otd.2017.1094
  • 4. Stover J, Rosen JE, Carvalho MN, Korenromp EL, Friedman HS, Cogan M, et al. The case for investing in the male condom. PLoS One. 2017 May 16;12(5):e0177108. doi: 10.1371/journal.pone.0177108. eCollection 2017
  • 5. Trussell J. Contraceptive failure in the United States. Contraception 2011; 83: 397–404.
  • 6. United Nations, Department of Economic and Social Affairs, Population Division. Trends in Contraceptive Use Worldwide 2015 (ST/ESA/SER.A/349) 2015; 23-26.
  • 7. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü. 2018 Türkiye Nüfus ve Sağlık Araştırması. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü, T.C. Kalkınma Bakanlığı ve TÜBİTAK. Aile planlanması. Türkiye; Ankara 2018; 83-105.
  • 8. Güngör S, Başer İ, Göktolga Ü, Özkömür E, Keskin U. Koitus interruptus (geri çekme) yönteminin etkinliği ve eğitim seviyesinin önemi. Gülhane Tıp Dergisi 2006; 48: 8-10.
  • 9. Fu TC, Hensel DJ, Beckmeyer JJ, Dodge B, Herbenick D. Considerations in the Measurement and Reporting of Withdrawal: Findings from the 2018 National Survey of Sexual Health and Behavior. J Sex Med. 2019 Aug;16(8):1170-1177. doi: 10.1016/j.jsxm.2019.05.022. Epub 2019 Jul 11.
  • 10. Jing HC, Stephanie T. Page. The current state of male hormonal contraception. Pharmacology & Therapeutics 2016; 163: 109–117.
  • 11. Vanya M, Devosa I, Barabás K, Bártfai G, Kozinszky Z. Choice of contraception at 6-8 weeks postpartum in south-eastern Hungary. Eur J Contracept Reprod Health Care. 2018 Feb;23(1):52-57. doi: 10.1080/13625187.2017.1422238. Epub 2018 Feb 2.
  • 12. Orji EO, Onwudiegwu U. Contraceptive practice among married market men in Nigeria. East Afr Med J. 2003 Jul;80(7):357-60.
  • 13. Kovavisarach E, Saringcarnan P. Coitus interruptus in female patients seeking services at Obstetrics and Gynecology Department in Rajavithi Hospital. J Med Assoc Thai. 2010 Dec;93(12):1356-9.
  • 14. Agyei WK, Migadde M. Demographic and sociocultural factors influencing contraceptive use in Uganda. J Biosoc Sci. 1995 Jan;27(1):47-60.
  • 15. Fagbamigbe AF, Adebowale AS, Morhason-Bello I. Survival analysis of time to uptake of modern contraceptives among sexually active women of reproductive age in Nigeria. BMJ Open. 2015 Dec 15;5(12):e008371. doi: 10.1136/bmjopen-2015-008371.
  • 16. Abiodun OM, Balogun OR. Sexual activity and contraceptive use among young female students of tertiary educational institutions in Ilorin, Nigeria. Contraception. 2009 Feb;79(2):146-9. doi: 10.1016/j.contraception.2008.08.002. Epub 2008 Nov 17.
  • 17. Paudel YR, Acharya K. Fertility Limiting Intention and Contraceptive Use among Currently Married Men in Nepal: Evidence from Nepal Demographic and Health Survey 2016. Biomed Res Int. 2018 Dec 23;2018:5970705. doi: 10.1155/2018/5970705. eCollection 2018.
  • 18. Heinemann K, Saad F, Wiesemes M, White S, Heinemann L. Attitudes toward male fertility control: results of a multinational survey on four continents. Human Reproduction Vol.20, No.2 pp. 2005; 549–556.
  • 19. Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Hormonal Male Contraception Summit GroupRate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006 Apr 29;367(9520):1412-20.
  • 20. Piotrowska K, Wang C, Swerdloff RS, Liu PY. Male hormonal contraception: hope and promise. Lancet Diabetes Endocrinol 2017;5: 214–23.
  • 21. Wang C, Festin MPR, Swerdloff RS. Male Hormonal Contraception: Where Are We Now? Curr Obstet Gynecol Rep (2016) 5:38–47 DOI 10.1007/s13669-016-0140-8
  • 22. Fernández-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010 Jun;95(6):2560-75. doi: 10.1210/jc.2009-2575.
  • 23. Martin CW, Anderson RA, Cheng L, Ho PC, van der Spuy Z, Smith KB, et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod. 2000 Mar;15(3):637-45.
  • 24. Glasier A. Acceptability of contraception for men: a review. Contraception 82 (2010) 453–456.
  • 25. Weston GC, Schlipalius ML, Bhuinneain MN, Vollenhoven BJ. Will Australian men use male hormonal contraception? A survey of a postpartum population. Med J Aust. 2002 Mar 4;176(5):208-10.
  • 26. Meriggiola MC, Cerpolini S, Bremner WJ, Mbizvo MT, Vogelsong KM, Martorana G, et al. Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. Hum Reprod. 2006 Aug;21(8):2033-40. Epub 2006 May 26.
  • 27. Eberhardt J, van Wersch A, Meikle N. Attitudes towards the male contraceptive pill in men and women in casual and stable sexual relationships. J Fam Plann Reprod Health Care. 2009 Jul;35(3):161-5. doi: 10.1783/147118909788707986.
  • 28. Dorman E, Bishai D. Demand for male contraception. Expert Rev Pharmacoecon Outcomes Res. 2012 Oct;12(5):605-13. doi: 10.1586/erp.12.52.
There are 28 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Orijinal Articles
Authors

İzzet Göker Küçük 0000-0003-3353-5848

Utku Eser This is me 0000-0002-7870-330X

Murat Çevik This is me 0000-0003-4451-177X

Raziye Gümüştakım 0000-0003-0195-0895

Kurtuluş Öngel 0000-0002-8846-2810

Publication Date December 20, 2020
Submission Date July 2, 2020
Published in Issue Year 2020 Volume: 14 Issue: 4

Cite

Vancouver Küçük İG, Eser U, Çevik M, Gümüştakım R, Öngel K. Birth Control Methods Used by Men and Their Attitudes towards the Male Birth Control Pill. TJFMPC. 2020;14(4):613-20.

English or Turkish manuscripts from authors with new knowledge to contribute to understanding and improving health and primary care are welcome.